Brief: Concord Biotech Says Granted Approval From USFDA For Marketing Its Teriflunomide Tablets
08/04/2025 16:26
April 8 (Reuters) - Concord Biotech Ltd CONB.NS: GRANTED APPROVAL FROM USFDA FOR MARKETING ITS TERIFLUNOMIDE TABLETS Source text: [ID:] Further company coverage: CONB.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval